ReviewFrontiers in oncology2024

Efficacy and safety of pembrolizumab in patients with advanced endometrial cancer: a systematic review and meta-analysis.

Biqiong Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.